Differentiation of members of the human herpesviridae family by radioimmunoassay
- PMID: 6268545
- PMCID: PMC350725
- DOI: 10.1128/iai.33.2.491-497.1981
Differentiation of members of the human herpesviridae family by radioimmunoassay
Abstract
Many individuals who are seronegative for one member of the human Herpesviridae family are strongly seropositive for other members. Using sera from such individuals, the radioimmunoassay technique demonstrated absence of antigen-antibody cross-reactions between varicella-zoster virus (VZV) and herpes simplex virus (HSV) at levels of less than one part in 1,000. Sera containing antibody to both HSV and VZV were absorbed with antigens of one agent without significantly altering the amount of remaining antibody to the other antigen. This further suggests that HSV and VZV do not share a common antigen. The same radioimmunoassay technique and serum absorption method that revealed no serological cross-reactions between HSV and VZV revealed the expected cross-reaction between HSV type 1 (HSV-1) and HSV-2. Reciprocally absorbed anti-HSV-1 and anti-HSV 2 sera were able to differentiate the two HSV types reliably. No cross-reactions were seen between cytomegalovirus, VZV, and HSV or between Epstein-Barr virus, VZV, and HSV. We postulate that heterotypic antibody responses sometimes observed for VZV after primary infections by HSV may not be due to shared antigens, but to activation of latent VZV infections, release of new VZV antigens, and consequent stimulation of new antibody production to VZV.
Similar articles
-
Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.J Med Virol. 1984;13(1):1-12. doi: 10.1002/jmv.1890130102. J Med Virol. 1984. PMID: 6319583
-
Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections.J Med Virol. 1989 May;28(1):30-7. doi: 10.1002/jmv.1890280108. J Med Virol. 1989. PMID: 2542443
-
Further evidence for common antigens in herpes simplex and varicella-zoster viruses.J Med Virol. 1982;9(1):27-36. doi: 10.1002/jmv.1890090105. J Med Virol. 1982. PMID: 6278070
-
[Prevention and therapy of herpesvirus infections].Zentralbl Bakteriol Mikrobiol Hyg B. 1985 Feb;180(2-3):107-20. Zentralbl Bakteriol Mikrobiol Hyg B. 1985. PMID: 2986378 Review. German.
-
Persistence, reactivation, and cell transformation by human herpeviruses: herpes simplex 1, 2 (HSV-1, HSV-2), cytomegalovirus (CMV), varicella-zoster (VZV), Epstein-Barr virus (EBV).Can J Microbiol. 1979 Mar;25(3):254-60. doi: 10.1139/m79-041. Can J Microbiol. 1979. PMID: 222414 Review. No abstract available.
Cited by
-
Comparison of immunofluorescence with commercial monoclonal antibodies to biochemical and biological techniques for typing clinical herpes simplex virus isolates.J Clin Microbiol. 1985 Nov;22(5):870-2. doi: 10.1128/jcm.22.5.870-872.1985. J Clin Microbiol. 1985. PMID: 2997273 Free PMC article.
-
A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2.Antimicrob Agents Chemother. 1982 Jul;22(1):55-61. doi: 10.1128/AAC.22.1.55. Antimicrob Agents Chemother. 1982. PMID: 6289741 Free PMC article.
-
Comparison of biological, biochemical, immunological, and immunochemical techniques for typing herpes simplex virus isolates.J Clin Microbiol. 1983 Mar;17(3):396-9. doi: 10.1128/jcm.17.3.396-399.1983. J Clin Microbiol. 1983. PMID: 6302130 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources